The authors suggest that ADAM9 influences tumour cells via two possible ways—interaction with adhesion molecules, or the proteolytic ‘shedding’ of signalling molecules, which leads to the activation of their receptors, including the EGF receptor and its ligands [46]. Here, ADAM9 is linked to neoplasm.